- Home
- RNAC vs ACRE Comparison
RNAC vs ACRE Comparison
Compare RNAC & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAC | ACRE |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.9M | 261.9M |
| IPO Year | 2016 | 2011 |
Fundamental Metrics
Financial Performance| Metric | RNAC | ACRE |
|---|---|---|
| Price | $9.18 | $4.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $34.00 | $5.38 |
| AVG Volume (30 Days) | 101.0K | ★ 489.1K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.58% |
| EPS Growth | N/A | ★ 26.17 |
| EPS | N/A | ★ 1.35 |
| Revenue | $2,797,000.00 | ★ $54,833,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.28 |
| P/E Ratio | ★ N/A | $3.50 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.60 | $4.14 |
| 52 Week High | $11.77 | $5.89 |
Technical Indicators
Market Signals| Indicator | RNAC | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 65.65 | 56.19 |
| Support Level | $5.89 | $4.69 |
| Resistance Level | $10.98 | $5.02 |
| Average True Range (ATR) | 0.44 | 0.16 |
| MACD | 0.14 | 0.03 |
| Stochastic Oscillator | 99.32 | 81.82 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a real estate investment trust mainly engaged in originating and investing in commercial real estate (CRE) loans and related investments. It operates in one segment, namely originating and managing a diversified portfolio of CRE debt-related investments. The company recognizes the majority of its revenues in the form of interest income, which it receives from loans.